Earth Science Tech (ETST) Receivables (2012 - 2026)
Earth Science Tech's (ETST) quarterly Receivables came in at $845945.0 in Q2 2026, up 147.61% on a YoY basis from $341644.0 in Q2 2025, and up 137.59% quarter-over-quarter from $356054.0 in Q1 2026.
Analysis
Earth Science Tech (ETST) Receivables (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Receivables for 12 consecutive years, with $845945.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables rose 147.61% year-over-year to $845945.0; the trailing twelve-month figure through Jun 2026 stood at $845945.0 (up 147.61% YoY), and the FY2026 full-year result was $356054.0, up 175.87% from the prior year.
- Receivables grew to $845945.0 in Q2 2026 per ETST's latest filing, from $356054.0 in the prior quarter.
- Across five years, Receivables topped out at $845945.0 in Q2 2026 and bottomed at $112826.0 in Q4 2023.
- Historically, Receivables has averaged $287070.8 across 4 years, with a median of $235423.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Receivables plunged 45.18% in 2025, then soared 175.87% in 2026.
- Over 4 years, Receivables stood at $112826.0 in 2023, then surged by 45.55% to $164221.0 in 2024, then jumped by 86.41% to $306118.0 in 2025, then surged by 176.35% to $845945.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $845945.0, $356054.0, and $306118.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 3.49 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 3.67 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.06 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.61 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 2.26 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 211.59 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 274.47 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 145.76 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 23.27 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 845,945.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 845,945.00 |
| Mar 31, 2026 | 356,054.00 |
| Dec 31, 2025 | 306,118.00 |
| Sep 30, 2025 | 227,189.00 |
| Jun 30, 2025 | 341,644.00 |
| Mar 31, 2025 | 129,064.00 |
| Dec 31, 2024 | 164,221.00 |
| Sep 30, 2024 | 203,942.00 |
| Jun 30, 2024 | 317,687.00 |
| Mar 31, 2024 | 235,423.00 |
| Dec 31, 2023 | 112,826.00 |
| Sep 30, 2023 | 180,861.00 |
| Mar 31, 2023 | 310,947.00 |
| Sep 30, 2021 | 5,456.00 |
| Jun 30, 2021 | 4,944.00 |
| Mar 31, 2021 | 6,108.00 |
| Dec 31, 2020 | 22,359.00 |
| Sep 30, 2020 | 25,998.00 |
| Jun 30, 2020 | 28,902.00 |
| Mar 31, 2020 | 38,933.00 |